75 related articles for article (PubMed ID: 18790251)
21. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.
Grotz WH; Mundinger FA; Gugel B; Exner VM; Kirste G; Schollmeyer PJ
Transplantation; 1995 Apr; 59(7):982-6. PubMed ID: 7709459
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density of the spine and femur in healthy Chinese men.
Zhang ZL; Qin YJ; Huang QR; Hu YQ; Li M; He JW; Zhang H; Liu YJ; Hu WW
Asian J Androl; 2006 Jul; 8(4):419-27. PubMed ID: 16763717
[TBL] [Abstract][Full Text] [Related]
24. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
Wang SX; Li H
Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
[TBL] [Abstract][Full Text] [Related]
25. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.
van den Ham EC; Kooman JP; Christiaans ML; van Hooff JP
Transpl Int; 2003 Feb; 16(2):82-7. PubMed ID: 12595969
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
27. Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients.
Grotz WH; Mundinger FA; Rasenack J; Speidel L; Olschewski M; Exner VM; Schollmeyer PJ
Nephrol Dial Transplant; 1995 Nov; 10(11):2096-100. PubMed ID: 8643174
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
[TBL] [Abstract][Full Text] [Related]
30. Changes in bone mass early after kidney transplantation.
Horber FF; Casez JP; Steiger U; Czerniak A; Montandon A; Jaeger P
J Bone Miner Res; 1994 Jan; 9(1):1-9. PubMed ID: 8154303
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Bone Disease in Kidney Transplant Recipients.
Alis G; Alis M; Erturk T; Karayagiz AH; Berber I; Cakir U
Transplant Proc; 2017 Apr; 49(3):509-511. PubMed ID: 28340823
[TBL] [Abstract][Full Text] [Related]
32. Bone density in heart or lung transplant recipients--a longitudinal study.
Wang TK; O'Sullivan S; Gamble GD; Ruygrok PN
Transplant Proc; 2013; 45(6):2357-65. PubMed ID: 23747143
[TBL] [Abstract][Full Text] [Related]
33. Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients.
Braith RW; Magyari PM; Fulton MN; Lisor CF; Vogel SE; Hill JA; Aranda JM
Transplantation; 2006 Apr; 81(8):1191-5. PubMed ID: 16641607
[TBL] [Abstract][Full Text] [Related]
34. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
35. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
[TBL] [Abstract][Full Text] [Related]
36. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women.
Liu SZ; Tian LF; Xu P; Zhuang GH; Zheng F; Tian J; Ning QL; Zhu BF; Lu SM; Yan H
Mol Biol Rep; 2011 Feb; 38(2):939-48. PubMed ID: 20490690
[TBL] [Abstract][Full Text] [Related]
37. Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: cross-sectional study.
Kusec V; Smalcelj R; Cvijetić S; Rozman B; Skreb F
Croat Med J; 2000 Dec; 41(4):396-400. PubMed ID: 11063762
[TBL] [Abstract][Full Text] [Related]
38. Bone disease in renal transplantation and pleotropic effects of vitamin D therapy.
Sikgenc MM; Paydas S; Balal M; Demir E; Kurt C; Sertdemir Y; Binokay F; Erken U
Transplant Proc; 2010 Sep; 42(7):2518-26. PubMed ID: 20832535
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
40. Nasal calcitonin.
Silverman SL
Endocrine; 1997 Apr; 6(2):199-202. PubMed ID: 9225136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
